From the FDA release "The FDA approval of CardioCel 3D is an important accomplishment for Admedus as we expand our ADAPT® tissue engineering portfolio. 3D is a pioneering new product"
From today "The Company does not consider that the FDA Grant of CardioCel® 3D itself, as opposed to the previous CardioCel® FDA clearance, is information that a reasonable person would expect to have a material effect on the price or value"
Which is it ?
Apparently when you're talking to potential investors its fantastic -when responding to an ASX please-explain, not so much.
From the FDA release "The FDA approval of CardioCel 3D is an...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.05 |
Change
-0.300(1.73%) |
Mkt cap ! $327.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $184.6K | 10.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 191 | $17.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.50 | 500 | 1 |
View Market Depth
| Last trade - 15.59pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |